Mechanistic implications for Escherichia coli cofactor-dependent phosphoglycerate mutase based on the high-resolution crystal structure of a vanadate complex.

The structure of Escherichia coli cofactor-dependent phosphoglycerate mutase (dPGM), complexed with the potent inhibitor vanadate, has been determined to a resolution of 1.30 A (R-factor 0.159; R-free 0.213). The inhibitor is present in the active site, principally as divanadate, but with evidence of additional vanadate moieties at either end, and representing a different binding mode to that observed in the structural homologue prostatic acid phosphatase. The analysis reveals the enzyme-ligand interactions involved in inhibition of the mutase activity by vanadate and identifies a water molecule, observed in the native E.coli dPGM structure which, once activated by vanadate, may dephosphorylate the active protein. Rather than reflecting the active conformation previously observed for E.coli dPGM, the inhibited protein's conformation resembles that of the inactive dephosphorylated Saccharomyces cerevisiae dPGM. The provision of a high-resolution structure of both active and inactive forms of dPGM from a single organism, in conjunction with computational modelling of substrate molecules in the active site provides insight into the binding of substrates and the specific interactions necessary for three different activities, mutase, synthase and phosphatase, within a single active site. The sequence similarity of E.coli and human dPGMs allows us to correlate structure with clinical pathology.

[1]  S. Grisolía,et al.  Influence of salt, substrate, and cofactor concentrations on the kinetic and mechanistic behavior of phosphoglycerate mutase. , 1968, Biochemistry.

[2]  E. Beutler Disorders due to enzyme defects in the red blood cell. , 1972, Advances in metabolic disorders.

[3]  [67] 2,3-Diphosphoglycerate mutase from human erythrocytes , 1975 .

[4]  Yeast phosphoglycerate mutate. Cyanogen bromide cleavage and amino acid sequence of an active-site peptide. , 1976, The Biochemical journal.

[5]  S. Grisolía,et al.  Vanadate increases oxygen affinity and affects enzyme activities and membrane properties of erythrocytes. , 1981, Biochemical and biophysical research communications.

[6]  H. Watson,et al.  Structure and activity of phosphoglycerate mutase. , 1981, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[7]  Disodium D-3-phosphoglycerate, a substrate to phosphoglycerate kinase , 1982 .

[8]  S. Dimauro,et al.  Muscle phosphoglycerate rnutase deficiency , 1982, Neurology.

[9]  G. Pons,et al.  Phylogeny and ontogeny of the phosphoglycerate mutases.--V. Inactivation of phosphoglycerate mutase isozymes by histidine-specific reagents. , 1982, Comparative biochemistry and physiology. B, Comparative biochemistry.

[10]  G. Pons,et al.  Effect of vanadate on the formation and stability of the phosphoenzyme forms of 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase and of phosphoglucomutase. , 1982, Biochimica et biophysica acta.

[11]  L. Fothergill,et al.  The complete amino acid sequence of human erythrocyte diphosphoglycerate mutase. , 1983, The EMBO journal.

[12]  W. Valentine,et al.  Hemolytic anemias and erythrocyte enzymopathies. , 1985, Annals of internal medicine.

[13]  Structure of trisodium d-2-phosphoglycerate hexahydrate , 1985 .

[14]  R. Read Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .

[15]  L. F. Hass,et al.  2,3-diphosphoglycerate phosphatase activity of phosphoglycerate mutase: stimulation by vanadate and phosphate. , 1987, Biochemistry.

[16]  M. Gresser,et al.  Inhibition of phosphatase and sulfatase by transition-state analogues. , 1988, Biochemistry.

[17]  U. Heinemann,et al.  Crystal structure of guanosine-free ribonuclease T1, complexed with vanadate (V), suggests conformational change upon substrate binding. , 1989, Biochemistry.

[18]  H. Watson,et al.  The phosphoglycerate mutases. , 1989, Advances in enzymology and related areas of molecular biology.

[19]  Y. Blouquit,et al.  Isolation, characterization, and structure of a mutant 89 Arg----Cys bisphosphoglycerate mutase. Implication of the active site in the mutation. , 1989, The Journal of biological chemistry.

[20]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[21]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[22]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[23]  G J Barton,et al.  ALSCRIPT: a tool to format multiple sequence alignments. , 1993, Protein engineering.

[24]  S Sakoda,et al.  The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency. , 1993, American journal of human genetics.

[25]  CRYSTAL AND MOLECULAR STRUCTURE OF PENTA-(CYCLOHEXYLAMMONIUM) D-2,3-DIPHOSPHOGLYCERATE TRIHEMIHYDRATE , 1993 .

[26]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[27]  G Schneider,et al.  Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. Implications for the reaction mechanism. , 1994, European journal of biochemistry.

[28]  D. Crans Aqueous Chemistry of Labile Oxovanadates: Relevance to Biological Studies , 1994 .

[29]  Muscle phosphoglycerate mutase deficiency: a study of a family with metabolic myopathy. , 1994, Functional neurology.

[30]  J. Tainer,et al.  Crystal structure of the human cell cycle protein CksHs1: single domain fold with similarity to kinase N-lobe domain. , 1995, Journal of molecular biology.

[31]  D. M. F. Aalten,et al.  PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules , 1996, J. Comput. Aided Mol. Des..

[32]  David S. Goodsell,et al.  Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 , 1996, J. Comput. Aided Mol. Des..

[33]  G. Sheldrick,et al.  SHELXL: high-resolution refinement. , 1997, Methods in enzymology.

[34]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[35]  C. Bond,et al.  Structure of a human lysosomal sulfatase. , 1997, Structure.

[36]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[37]  L. Pedersen,et al.  Crystal structure of estrogen sulphotransferase , 1997, Nature Structural Biology.

[38]  Human erythrocyte bisphosphoglycerate mutase: inactivation by glycation in vivo and in vitro. , 1998, Journal of biochemistry.

[39]  L. Pedersen,et al.  The Sulfuryl Transfer Mechanism , 1998, The Journal of Biological Chemistry.

[40]  D. Schomburg,et al.  X-ray structure determination of a vanadium-dependent haloperoxidase from Ascophyllum nodosum at 2.0 A resolution. , 1999, Journal of molecular biology.

[41]  J. W. Campbell,et al.  Structure of a phosphoglycerate mutase:3-phosphoglyceric acid complex at 1.7 A. , 1999, Acta crystallographica. Section D, Biological crystallography.

[42]  S. Phillips,et al.  Polyanionic inhibitors of phosphoglycerate mutase: combined structural and biochemical analysis. , 1999, Journal of molecular biology.

[43]  A. Bairoch,et al.  The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999 , 1999, Nucleic Acids Res..

[44]  S. Phillips,et al.  Sulphate ions observed in the 2.12 A structure of a new crystal form of S. cerevisiae phosphoglycerate mutase provide insights into understanding the catalytic mechanism. , 1999, Journal of molecular biology.

[45]  B. Stec,et al.  A Model of the Transition State in the Alkaline Phosphatase Reaction* , 1999, The Journal of Biological Chemistry.

[46]  S. Dimauro,et al.  Manifesting heterozygotes in a Japanese family with a novel mutation in the muscle-specific phosphoglycerate mutase (PGAM-M) gene , 1999, Neuromuscular Disorders.

[47]  P W Kuchel,et al.  Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: in vivo kinetic characterization of 2,3-bisphosphoglycerate synthase/phosphatase using 13C and 31P NMR. , 1999, The Biochemical journal.

[48]  The role of the C-terminal region in phosphoglycerate mutase. , 1999 .

[49]  Anastassis Perrakis,et al.  Automated protein model building combined with iterative structure refinement , 1999, Nature Structural Biology.

[50]  M. F. White,et al.  The two analogous phosphoglycerate mutases of Escherichia coli , 1999, FEBS letters.

[51]  M. J. Jedrzejas,et al.  Structure and mechanism of action of a novel phosphoglycerate mutase from Bacillus stearothermophilus , 2000, The EMBO journal.

[52]  A. Houdusse,et al.  Three conformational states of scallop myosin S1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. F. White,et al.  High Resolution Structure of the Phosphohistidine-activated Form of Escherichia coli Cofactor-dependent Phosphoglycerate Mutase* , 2001, The Journal of Biological Chemistry.

[54]  E. Lamani,et al.  A cofactor‐dependent phosphoglycerate mutase homolog from Bacillus stearothermophilus is actually a broad specificity phosphatase , 2001, Protein science : a publication of the Protein Society.